Biophysical studies of T-cell receptors and their ligands

Current Opinion in Immunology

Volumn 8, Issue 1, 1996, Pages 93-100

  Fremont, Daved H ^a,b   Rees, William A ^b   Kozono, Haruo ^b  

^a Columbia University ^*  (United States)

^b HOWARD HUGHES MEDICAL INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LIGAND; SUPERANTIGEN; T LYMPHOCYTE RECEPTOR;

ANTIGEN RECOGNITION; CELL; CRYSTAL STRUCTURE; LIGAND BINDING; MAJOR HISTOCOMPATIBILITY COMPLEX; REVIEW; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION;

EID: 0029883778     PISSN: 09527915     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0952-7915(96)80111-7     Document Type: Article

References (80)

1. Hogquist KA, Jameson SC, Heath WR, Howard JL, Bevan MJ, Carbone FR: T cell receptor antagonist peptides induce positive selection. Cell 1994, 76:17-27.
2. Ashton-Rickardt PG, Bandeira A, Delaney JR, Kaer LV, Pricher H-P, Zinkernagel RM, Tonegawa S: Evidence for a differential avidity model of T cell selection in the thymus. Cell 1994, 76:651-663.
3. Yoon ST, Dianzai U, Bottomly K, Janeway JCA: Both high and low avidity antibodies to the T cell receptor can have agonist or antagonist activity. Immunity 1994, 1:563-559. In support of a conformational change model of T-cell activation, this paper indicates that the avidity of anti-TCR antibodies does not correlate with their ability to activate T cells.
4. Janeway CA: Ligands for the T-cell receptor: hard times for the avidity models. Immunol Today 1995, 16:223-225.
5. Silver ML, Parker KC, Wiley DC: Reconstitution by MHC-restricted peptides of HLA-A2 heavy chain with beta 2-microglobulin, in vitro. Nature 1991, 350:619-622.
6. Matsumura M, Saito Y, Jackson MR, Song ES, Peterson PA: In vitro peptide binding to soluble empty class I major histocompatibility complex molecules isolated from transfected Drosophila melanogaster cells. J Biol Chem 1992, 267:23589-23595.
7. Stern LJ, Wiley DC: The human class II MHC protein HLA-DR1 assembles as empty a heterodimers in the absence of antigenic peptide. Cell 1992, 68:465-477.
8. Kozono H, White J, Clements J, Marrack P, Kappler JW: Production of soluble MHC class II proteins with covalently bound single peptides. Nature 1994, 369:151-154.
9. Traunecker A, Dolder B, Oliveri F, Karjalainen K: Solubilizing the T-cell receptor - problems In solution. Immunol Today 1989, 10:22-25.
10. Gregoire C, Rebai N, Schweisguth F, Necker A, Mazza G, Auphan N, Millward A, Scmitt-Verhulst A-M, Malissen B: Engineered secreted T-cell receptor αβ heterodimers. Proc Natl Acad Sci USA 1991, 88:8077-8081.
11. Weber S, Traunecker A, Oliveri F, Gerhard W, Karajalainen K: Specific low-affinity recognition of major histocompatibility complex plus peptide by soluble T-cell receptor Nature 1992, 356:793-796.
12. Chang H-C, Bao Z-Z, Yao Y, Tse A, Goyarts E, Madsen M, Kawasaki E, Brauer P, Sacchettini J, Nathenson S, Reinherz E: A general method for facilitating heterodimeric pairing between two proteins: application to expression of α and β T-cell receptor extracellular-segments. Proc Natl Acad Sci USA 1994, 91:11408-11412. Leucine zippers on the carboxyl termini of TCR α and β chains are shown to preferentially stabilize a functional αβ heterodimer.
13. Engel I, Ottenhoff T, Klausner R: High-efficiency expression and solubllizatlon of functional T cell antigen receptor heterodimers. Science 1992, 256:1318-1321.
14. Seth A, Stern LJ, Ottenhoff TH, Engel I, Owne MJ, Lamb JR, Klausner RD, Wiley DC: Binary and ternary complexes between T-cell receptor, class II MHC and superantigen in vitro. Nature 1994, 369:324-327. Native gel electrophoresis and SPR are used to demonstrate the formation of superantigen stabilized, TCR-class II MHC complexes.
15. Matsui K, Boniface JJ, Reay PA, Schild H, De St Groth BF, Davis MM: Low affinity Interaction of peptide-MHC complexes with T cell receptors. Science 1991, 254:1788-1791.
16. Kurucz I, Jost C, George A, Andrew S, Segal D: A bacterially expressed single-chain Fv construct from the 2B4 T-cell receptor. Proc Natl Acad Sci USA 1993, 90:3830-3834.
17. SooHoo WF, Lacy MJ, Denzin LK, Voss EW Jr, Hardman KD, Kranz DM: Characterization of a single-chain T-cell receptor expressed in Escherichia coli. Proc Natl Acad Sci USA 1992, 69:4759-4763.
18. Chung S, Wucherpfennig K, Friedman S, Hafler D, Strominger J: Functional three-domain single-chain T-cell receptors. Proc Natl Acad Sci USA 1994, 91:12654-12658. This paper describes an interesting observation concerning the importance of the Cβ domain to the structural integrity of a TCR heterodimer produced in Escherichia coli.
19. Ward E: Secretion of T cell receptor fragments from recombinant Escherichia coli cells. J Mol Biol 1992, 224:885-890.
20. Novotny J, Ganju R, Smiley S, Hussey R, Luther M, Recny M, Siliciano R, Reinharz E: A soluble, single-chain T-cell receptor fragment endowed with antigen-combining properties. Proc Natl Acad Sci USA 1991, 88:8646-8650.
21. Reiter Y, Kurucz I, Brinkmann U, Jung S-H, Lee B, Segal D, Pastan I: Construction of a functional disulfide-stabllized TCR Fv indicates that antibody and TCR Fv frameworks are very similar in structure. Immunity 1995, 2:281-287. A successful method for the production of antibody Fv fragments in E. coli is employed for the production of soluble disulfide-linked TCR Vα and Vβ fragments.
22. Collins EJ, Garboczi DN, Karpusas MN, Wiley DC: The three dimensional structure of a class I major histocompatibility complex molecule missing the alpha 3 domain of the heavy chain. Proc Natl Acad Sci USA 1995, 92:1218-1221.
23. Boulot G, Bentley G, Karjalainen K, Mariuzza R: Crystallization and preliminary X-ray diffraction analysis of the β-chain of a T-cell antigen receptor. J Mol Biol 1994, 235:795-797.
24. Fields B, Ysern X, Poljak R, Shao X, Ward E, Mariuzza R: Crystallization and preliminary X-ray diffraction study of a bactcrially produced T-cell antigen deceptor Vα domain. J Mol Biol 1994, 239:339-341.
25. Schneck J, Maloy WL, Coligan JE, Margulies DH: Inhibition of an allospecific T cell hybridoma by soluble class I proteins and peptides: estimation of the affinity of a T cell receptor for MHC. Cell 1989, 56:47-55.
26. Sykulev Y, Brunmark A, Jackson M, Cohen RJ, Peterson PA, Eisen HN: Kinetics and affinity of reactions between an antigen-specific T cell receptor and peptide-MHC complexes. Immunity 1994, 1:15-22. See annotation [27*].
27. Sykulev Y, Brunmark A, Tsomides TJ, Kageyama S, Jackson M, Peterson PA, Eisen HN: High-affinity reactions between antigen-specific T-cell receptors and peptides associated with allogeneic and syngeneic major histocompatibility complex class I proteins. Proc Natl Acad Sci USA 1994, 91:11487-11491. Along with [26*], this paper explores TCR-MHC binding kinetics using soluble class I molecules and cell surface TCR.
28. Van der Merwe PA, Barclay AN: Transient intercellular adhesion: the importance of weak protein-protein interactions. Trends Biochem Sci 1994, 19:354-358.
29. Corr M, Slantez A, Boyd L, Jelonek M, Khilko S, Al-Ramadi B, Kim Y, Maher S, Bothwell A, Margulies DH: T cell receptor-MHC class I peptlde interactions: affinity, kinetics, and specificity. Science 1994, 265:946-949. This paper and [30*] are the first demonstrations of the fast, kinetic on and off rates for TCR-MHC interactions using soluble components and the BIAcore biosensor system
30. Matsui K, Boniface JJ, Steffner P, Reay PA, Davis MM: Kinetics of T-cell receptor binding to peptide/I-Ek complexes: correlation of the dissociation rate with T-cell responsiveness. Proc Natl Acad Sci USA 1994, 91:12862-12866. See annotation [29*].
31. Al-Ramadi B, Jeloneck M, Boyd L, Margulies D, Bothwell A: Lack of strict correlation of functional sensitization with the apparent affinity of MHC/peptide complexes for the TCR. J Immunol 1995, 155:662-673. This paper demonstrates a general correlation between TCR-class I affinities and T-cell activation, with notable exceptions.
32. Luescher IF, Vivier E, Layer A, Mahiou J, Godeau F, Malissen B, Romero P: CD8 modulation of T-cell antigen receptor-ligand interactions on living cytotoxic T lymphocytes. Nature 1995, 373:353-356.
33. Bjorkman PJ, Saper MA, Samraoui B, Bennett WS, Strominger JL, Wiley DC: Structure of the human class I histocompatibility antigen, HLA-A2. Nature 1987, 329:506-512.
34. b. Science 1992, 257:919-927.
35. Zhang W, Young AC, Imarai M, Nathenson SG, Sacchattini JC: Crystal structure of the major histocompatibility complex class I H-2Kb molecule containing a single viral peptide: implications for peptide binding and T-cell receptor recognition. Proc Natl Acad Sci USA 1992, 89:8403-8407.
36. Silver ML, Guo HC, Strominger JL, Wiley DC: Atomic structure of a human MHC molecule presenting an influenza virus peptide. Nature 1992, 360:367-369.
37. Madden DR, Garboczi DN, Wiley DC: The antigenic identity of peptide-MHC complexes: a comparison of the conformations of five viral peptides presented by HLA-A2. Cell 1993, 75:693-708.
38. Young AC, Zhang W, Sacchettini JC, Nathenson SG: The three-dimensional structure of H-2Db at 2.4 Å resolution: implications for antigen-determinant selection. Cell 1994, 76:39-50.
39. Stern L, Brown G, Jardetsky T, Gorga Jm Urban R, Strominger J, Wiley D: Crystal strucutre of the human class II MHC protein HLA-DR1 complexed with an antigenic peptide from influenza virus. Nature 1994, 368:215-221.
40. Ghosh P, Amaya M, Mellins E, Wiley DC: The structure of an intermediate in class II MHC maturation: CLIP bound to HLA-DR3. Nature 1995, 378:457-462.
41. Fremont DH, Hendrickson WA, Marrack P, Kappler JW: Structures of an MHC class II molecule with covalently bound single peptides. Science 1996, in press.
42. Wang CR, Castano AR, Peterson PA, Slaughter C, Fischer-Lindahl K, Deisenhofer J: Nonclassical binding of formylated peptide in crystal structure of the MHC class Ib molecule H2-M3. Cell 1995, 82:655-664.
43. Jardetzky TS, Brown JH, Gorga JC, Stern U, Urban RG, Chi YI, Stauffacher C, Strominger JL, Wiley DC: Three-dimensional structure of a human class II histocompatibility molecule complexed with superantigen. Nature 1994, 368:711-718.
44. Kim J, Urban RG, Strominger JL, Wiley DC: Toxic shock syndrome toxin-1 complexed with a class II major histocompatibility molecule HLA-DR1. Science 1994, 266:1870-1874.
45. Wang J, Yan Y, Garrett TPJ, Liu J, Rogers DW, Garlick RL, Tarr GE, Husain Y, Reinherz EL, Harrison SC: Atomic structure of a fragment of human CD4 containing two immunoglobulin-like domains. Nature 1990, 348:411-418.
46. Ryu S-E, Kwong PD, Truneh A, Porter TG, Arthos J, Rosenberg M, Dai XP, Xuong NH, Axel R, Sweet RW, Hendrickson WA: Crystal structure of an HIV-binding recombinant fragment of human CD4. Nature 1990, 348:419-426.
47. Leahy DJ, Axel R, Hendrickson WA: Crystal structure of a soluble form of the human T cell coreceptor CD8 at 2.6 Å resolution. Cell 1992, 68:1145-1162.
48. Hatada M, Lu X, Laird E, Green J, Morgenstern J, Lou M, Marr C, Phillips T, Ram M, Theriault K, Zoller M, Karas J: Molecular basis for interaction of the protein tyrosine kinase ZAP-70 with the T-cell receptor. Nature 1995, 377:32-38.
49. Bentley G, Boulot G, Karjalainen K, Mariuzza R: Crystal structure of the β chain of a T cell antigen receptor. Science 1995, 267:1984-1987. This paper describes the first structure determination of a TCR β chain, establishes the basic immunoglobulin-fold similarities and reveals an extensive interaction between the Vβ and Cβ domains
50. Fields BA, Ober B, Malchiodi EL, Lebedeva MI, Braden BC, Ysern X, Kim JL, Shao X, Ward S, Mariuzza RA: Crystal structure of the V α domain of a T cell antigen receptor. Science 1995, 270:1821-1824. Describes the structure of an E. coli expressed Vα domain that exhibits a unique immunoglobulin-like fold. Individual Vα domains were found to pack in a tetrameric assembly in the crystal.
51. Davis MM, Bjorkman PJ: T-cell antigen receptor genes and T-cell recognition. Nature 1988, 334:395-402.
52. Chothia C, Boswell DR, Lesk AM: The outline structure of the T-cell αβ receptor. EMBO J 1988, 7:3745-3755.
53. Claverie J, Prochnicka-Chalufour A, Bougueleret L: Implications of a Fab-like structure for the T-cell receptor. Immunol Today 1989, 10:10-14.
54. Sun R, Shepherd SE, Geier SS, Thomson CT, Sheil JM, Nathenson SG: Evidence that the antigen receptors of cytotoxic T lymphocytes interact with a common recognition pattern on the H-2Kb molecule. Immunity 1995, 3:573-582.
55. Malchiodi EL, Einstein E, Fields BA, Ohlendori DH, Schlievert PM, Karjalainen K, Mariuzza RA: Superantigen binding to a T cell receptor β chain of known three-dimensional structure. J Exp Med 1995, 182:1833-1845. A comprehensive study of the binding of superantigens to a soluble murine β chain as analyzed by SPR and equilibrium sedimentation.
56. Herman A, Kappler JW, Marrack P, Pullen AM: Superantigens: mechanism of T-cell stimulation and role in immune responses. Annu Rev Immunol 1991, 9:745-772.
57. Brown JH, Jardetzky TS, Gorga JC, Stern LJ, Urban RG, Strominger JL, Wiley DC: Three-dimensional structure of the human class II histocompatibility antigen HLA-DR1. Nature 1993, 364:33-39.
58. Schafer PH, Pierce SK, Jardetzky TS: The structure of MHC class II: a role for dimer of dimers. Semin Immunol 1995, 7:389-398.
59. Jorgensen JL, Esser U, De St Groth BF, Reay PA, Davis MM: Mapping T-cell receptor-peptide contacts by variant peptide immunization of single-chain transgenics Nature 1992, 355:224-229.
60. Hong SC, Chelouche A, Lin RH, Shaywitz D, Braunstein NS, Glimchet L, Janeway CAJ: An MHC interaction site maps to the amino-terminal half of the T cell receptor alpha chain variable domain. Cell 1992, 69:999-1009.
61. Davis M, Y-H Chien: Topology and affinity of T-cell receptor mediated recognition of peptide-MHC complexes. Curr Opin Immunol 1993, 5:45-49.
62. Germain RN: Seeing double. Curr Biol 1993, 3:586-589
63. Davis MM: Serial engagement proposed. Nature 1995,375:104.
64. Sun J, Leahy DJ, Kavathas PB: Interaction between CD8 and major histocompatibility complex (MHC) class I mediated by multiple contact surfaces that include the α2 and α3 domains of MHC class I. J Exp Med 1995, 182:1275-1280.
65. Shapiro L, Fannon AM, Kwong PD, Thompson A, Lehmann MS, Grubel G, Legrad J-F, Als-Neilson J, Colman DR, Hendrickson WA: Structural basis of cell-cell adhesion by cadherins. Nature 1995, 374:327-337.
66. Valitutti S, Muller S, Cella M, Padovan E, Lanzavecchia A: Serial triggering of many T-cell receptors by few peptide-MHC complexes. Nature 1995, 375:148-151.
67. Ullrich A, Schlessinger J: Signal transduction by receptors with tyrosine kinase activity. Cell 1990, 61:203-212.
68. Bork P, Holm L, Sander C: The immunoglobulin fold: structural classification, sequence patterns and common core. J Mol Biol 1994, 242:309-320.
69. Strong R, Penny D, Feldman RR, Weiner L, Boniface JJ, Davis M, Bjorkman P: Engineering and expression of a secreted murine TCR with reduced N-linked glycosylation. J Immunol 1994, 153:4111-4121.
70. Lin A, Devaux B, Green A, Sagerstrom C, Elliot J, Davis M: Expression of T cell antigen receptor heterodimers in a lipid-linked form. Science 1990, 249:667-679.
71. Gascoigne N, Goodnow C, Dudzik K, Oi V, Davis M: Secretion of a chimeric T-cell receptor-immunoglobulin protein. Proc Natl Acad Sci USA 1987, 84:2936-2940.
72. Slanetz A, Bothwell A: Heterodimeric, disurfide-linked α/β T cell receptors in solution. Eur J Immunol 1991, 21:179-183.
73. Hilyard K, Reybum H, Chung S, Bell J, Strominger J: Binding of soluble natural ligands to a soluble human T-cell receptor fragment produced in Escherichia coli. Proc Natl Acad Sci USA 1994, 91:9057-9061.
74. Kappler J, White J, Kozono H, Clements J, Marrack P: Binding of a soluble αβ T-cell receptor to superantigen/major histocompatibility complex ligands. Proc Natl Acad Sci USA 1994, 91:8462-8466.
75. Basi G, Riggs M, Nash K, Singer R: Antibodies to soluble human T cell receptor β chain recognize multiple epitopes on cell surface TCR. J Immunol Methods 1992, 155:175-191.
76. Ward E: Expression and secretion of T-cell receptor Vα and Vβ domains using E. coli as a host. Scand J Immunol 1991, 34:215-220.
77. Mariuzza R, Winter G: Secretion of a homodimeric VαCκ T-cell receptor immunoglobulin chimeric protein. J Biol Chem 1989, 264:7310-7316
78. Eilat D, Kikuchi G, Coligan J, Shevach E: Secretion of a soluble, chimeric γδ T-cell receptor-immunoglobulin heterodimer. Proc Natl Acad Sci USA 1992, 89:6871-6875.
79. Davodeau F, Houde I, Boulot G, Romagne F, Necker A, Canavo N, Hallet M, Vie H, Jacques Y, Mariuzza R, Bonnville M: Secretion of disulfide-linked human T-cell receptor γδ heterodimers. J Biol Chem 1993, 268:15455-15460.
80. Porto JD, Johansen TE, Catipovic B, Parfiit DJ, Tuveson D, Gether U, Kozlowski S, Fearon DT, Schneck J: A soluble divalent class I major histocompatibility complex molecule inhibits alloreactive T cells at nanomolar concentrations. Proc Natl Acad Sci USA 1993, 90:6671-6675.